Even vulnerable people, who are at risk of severe Covid-19, achieved good antibody levels after three doses of mRNA vaccine. This is shown by a study from the University of Gothenburg on patients having undergone a bone marrow transplant or with liver disease, including cirrhosis. The aim of the study, which has been published in the journal Infectious Diseases, was to investigate the effects of repeated vaccinations and hybrid immunity against Covid-19 among particularly vulnerable individuals. Hybrid immunity refers to the protection provided by vaccination in combination with SARS-CoV-2 infection. The results demonstrate how levels of Covid-19 antibodies build up following each successive vaccine dose in those with a fundamentally deficient immune defense. This is a field where there remains limited knowledge. Equivalent after the third dose The study included 38 patients with liver cirrhosis, 36 bone marrow transplant recipients, 14 patients with autoimmune liver disease, and 20 healthy controls. All patients were cared...
🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!




